Beijing Labtech Instruments Co., Ltd. (SHA:688056)
34.41
+0.31 (0.91%)
Jul 31, 2026, 3:00 PM CST
SHA:688056 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 388.78 | 401.08 | 424.01 | 415.99 | 355 | 368.86 |
Revenue Growth | -6.90% | -5.41% | 1.93% | 17.18% | -3.76% | 5.81% |
Gross Profit Gross Profit Growth | 176.29 | 180.02 | 190.94 | 182 | 168.67 | 178.36 |
Operating Income Operating Income Growth | 29.81 | 37.35 | 39.77 | 25.82 | 43.31 | 68.35 |
Net Income Net Income Growth | 34.24 | 40.4 | 39.15 | 27.56 | 44.62 | 69.41 |
Earnings Per Share EPS Growth | 0.51 | 0.60 | 0.59 | 0.41 | 0.67 | 1.04 |
EPS Growth | -16.29% | 1.70% | 43.90% | -38.81% | -35.58% | -11.11% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Environmental Protection Industry Environmental Protection Industry Growth | 73.64 |
Research Institutes/Universities Research Institutes/Universities Growth | 37.96 |
Comprehensive Third-Party Testing Comprehensive Third-Party Testing Growth | 22.42 |
Food and Drug Industry Food and Drug Industry Growth | 17.34 |
Medical Industry Medical Industry Growth | 36.58 |
Disease Control Disease Control Growth | 23.19 |
Geology/minerals/energy Geology/minerals/energy Growth | 20.74 |
Semiconductor Semiconductor Growth | 19.09 |
Others Others Growth | 147.26 |
Total Total Growth | 398.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 497.99 | 520.15 | 524.07 | 548 | 543.19 | 569.58 |
Total Debt Total Debt Growth | 1.76 | 1.83 | 2.87 | 2.93 | 0.33 | 0.6 |
Net Cash (Debt) Net Cash Growth | 496.23 | 518.33 | 521.2 | 545.06 | 542.86 | 568.98 |
Net Cash Growth | -4.30% | -0.55% | -4.38% | 0.41% | -4.59% | -7.71% |
Net Cash Per Share Net Cash Per Share Growth | 7.40 | 7.70 | 7.86 | 8.11 | 8.15 | 8.52 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 22 | 38.03 | 55.15 | 42.6 | 7.59 | 49.08 |
Capital Expenditures CapEx Growth | -5.08 | -4.72 | -4.97 | -26.37 | -27.45 | -77.48 |
Free Cash Flow Free Cash Flow Growth | 16.92 | 33.31 | 50.18 | 16.22 | -19.86 | -28.4 |
Free Cash Flow Growth | -65.79% | -33.63% | 209.29% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 45.34% | 44.88% | 45.03% | 43.75% | 47.51% | 48.35% |
Operating Margin | 7.67% | 9.31% | 9.38% | 6.21% | 12.20% | 18.53% |
Pretax Margin | 9.99% | 11.50% | 10.31% | 6.84% | 14.42% | 22.21% |
Profit Margin | 8.81% | 10.07% | 9.23% | 6.63% | 12.57% | 18.82% |
FCF Margin | 4.35% | 8.30% | 11.83% | 3.90% | -5.59% | -7.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.720 | 0.800 | 0.200 | 0.350 |
Dividend Per Share Growth | -79.17% | -79.17% | -10.00% | 300.00% | -42.86% | 16.67% |
Dividend Yield | 0.44% | 0.45% | 2.52% | 2.54% | 0.53% | 0.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 67.39 | 55.56 | 49.74 | 81.75 | 60.99 | 62.14 |
Forward PE | - | 39.54 | 37.81 | 34.11 | 30.78 | 47.69 |
P/FCF Ratio | 135.79 | 67.39 | 38.81 | 138.88 | - | - |
PS Ratio | 5.91 | 5.60 | 4.59 | 5.42 | 7.67 | 11.69 |